These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36834629)

  • 21. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the BCG vaccine a useful tool against COVID-19?
    Zhelezova G; Mateeva V; Mateev G
    Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fiction and Facts about BCG Imparting Trained Immunity against COVID-19.
    Kaur G; Singh S; Nanda S; Zafar MA; Malik JA; Arshi MU; Lamba T; Agrewala JN
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():980711. PubMed ID: 36875134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of trained immunity in COVID-19: Lessons for the next pandemic.
    Netea MG; Ziogas A; Benn CS; Giamarellos-Bourboulis EJ; Joosten LAB; Arditi M; Chumakov K; van Crevel R; Gallo R; Aaby P; van der Meer JWM
    Cell Host Microbe; 2023 Jun; 31(6):890-901. PubMed ID: 37321172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superinfection with SARS-CoV-2 Has Deleterious Effects on Mycobacterium bovis BCG Immunity and Promotes Dissemination of Mycobacterium tuberculosis.
    Hildebrand RE; Chandrasekar SS; Riel M; Touray BJB; Aschenbroich SA; Talaat AM
    Microbiol Spectr; 2022 Oct; 10(5):e0307522. PubMed ID: 36200898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development.
    Pasco ST; Anguita J
    Cells; 2020 Sep; 9(9):. PubMed ID: 32948003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCG and SARS-CoV-2-What Have We Learned?
    Kulesza J; Kulesza E; Koziński P; Karpik W; Broncel M; Fol M
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.
    Gong W; Mao Y; Li Y; Qi Y
    Int Immunopharmacol; 2022 Jul; 108():108870. PubMed ID: 35597119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.
    Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
    Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
    Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis, BCG Vaccination, and COVID-19: Are They Connected?
    Borges KCM; da Costa AC; de Souza Barbosa LC; Ribeiro KM; Dos Anjos LRB; Kipnis A; Junqueira-Kipnis AP
    Mini Rev Med Chem; 2022; 22(12):1631-1647. PubMed ID: 34983348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].
    Kalyuzhin OV; Andronova TM; Karaulov AV
    Ter Arkh; 2020 Dec; 92(12):195-200. PubMed ID: 33720594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
    Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
    Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base.
    Nachega JB; Maeurer M; Sam-Agudu NA; Chakaya J; Katoto PDM; Zumla A
    Int J Infect Dis; 2021 Dec; 113 Suppl 1():S78-S81. PubMed ID: 33794380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
    Khade SM; Yabaji SM; Srivastava J
    Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic].
    Kalyuzhin OV; Andronova TM; Karaulov AV
    Ter Arkh; 2021 Jan; 93(1):108-113. PubMed ID: 33720635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.
    Du J; Su Y; Wang R; Dong E; Cao Y; Zhao W; Gong W
    Front Immunol; 2023; 14():1118378. PubMed ID: 36798128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada.
    Pépin J; Labbé AC; Carignan A; Parent ME; Yu J; Grenier C; Beauchemin S; De Wals P; Valiquette L; Rousseau MC
    Vaccine; 2021 Dec; 39(50):7300-7307. PubMed ID: 34493410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.